N J Curtin Selected Research

N J Curtin Research Topics

Disease

17	Neoplasms (Cancer) 09/2014 - 01/2000
5	Breast Neoplasms (Breast Cancer) 07/2011 - 07/2000
3	Colonic Neoplasms (Colon Cancer) 09/2014 - 02/2000
2	Triple Negative Breast Neoplasms 02/2012 - 11/2011
1	Ataxia Telangiectasia (Louis Bar Syndrome) 07/2011
1	Ovarian Neoplasms (Ovarian Cancer) 07/2011
1	Medulloblastoma 11/2010
1	Genomic Instability 10/2008
1	Prostatic Neoplasms (Prostate Cancer) 12/2007
1	Transfusion Reaction 06/2007
1	Clinical Deterioration 06/2007
1	Hemolysis 06/2005
1	Carcinoma (Carcinomatosis) 07/2001
1	Mesothelioma 05/2001
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2001
1	Neutropenia 05/2001
1	Squamous Cell Carcinoma of Head and Neck 05/2001
1	Colorectal Neoplasms (Colorectal Cancer) 11/2000

Drug/Important Bio-Agent (IBA)

7	Poly(ADP-ribose) Polymerase InhibitorsIBA 07/2014 - 07/2000
3	rucaparibIBA 09/2014 - 11/2010
3	DNA (Deoxyribonucleic Acid)IBA 08/2013 - 11/2000
3	Temozolomide (Temodar)FDA LinkGeneric 11/2010 - 07/2000
3	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 11/2010 - 11/2000
3	NU2058IBA 01/2010 - 07/2000
3	ThymidineIBA 07/2001 - 02/2000
3	Pemetrexed (MTA)FDA Link 07/2001 - 02/2000
2	4- cyclohexylmethoxy- 5- nitrosopyrimidine- 2,6- diamineIBA 07/2011 - 07/2000
2	purineIBA 01/2010 - 07/2000
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2010 - 07/2000
2	Poly (ADP-Ribose) Polymerase-1IBA 07/2009 - 10/2008
2	HypoxanthineIBA 07/2001 - 02/2000
1	trioctyl phosphine oxide (TOPO)IBA 09/2014
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 09/2014
1	PoisonsIBA 09/2014
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 09/2014
1	CamptothecinIBA 09/2014
1	Progesterone Receptors (Progesterone Receptor)IBA 02/2012
1	iniparibIBA 11/2011
1	Phosphotransferases (Kinase)IBA 07/2011
1	MethyltransferasesIBA 11/2010
1	NU6102IBA 01/2010
1	Small Interfering RNA (siRNA)IBA 01/2010
1	CyclinsIBA 01/2010
1	Estrogens (Estrogen)FDA Link 01/2010
1	Cyclin-Dependent Kinase 2IBA 01/2010
1	A-Form DNA (A-DNA)IBA 10/2008
1	AndrogensIBA 12/2007
1	VA 061 (VA061)IBA 12/2007
1	Androgen Antagonists (Antiandrogens)IBA 12/2007
1	AntibodiesIBA 06/2007
1	Folic Acid AntagonistsIBA 07/2001
1	Cisplatin (Platino)FDA LinkGeneric 05/2001
1	NucleosidesIBA 02/2001
1	EnzymesIBA 11/2000
1	Antineoplastic Agents (Antineoplastics)IBA 11/2000
1	olomoucineIBA 07/2000
1	pyrimidineIBA 07/2000
1	alvocidib (flavopiridol)IBA 07/2000
1	Topotecan (Hycamtin)FDA LinkGeneric 07/2000
1	NU 1025IBA 07/2000
1	Adenosine Triphosphate (ATP)IBA 01/2000
1	6R- 2',5'- thienyl- 5,10- dideazatetrahydrofolic acidIBA 01/2000

Therapy/Procedure

5	Therapeutics 07/2014 - 10/2008
2	Drug Therapy (Chemotherapy) 10/2011 - 11/2000
1	Blood Transfusion (Blood Transfusions) 06/2007
1	Transplantation 06/2005
1	Radiotherapy 11/2000